TRPC channels and their implications for neurological diseases

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 1, 2010, Pages 94-104

  Selvaraj, Senthil ^a   Sun, Yuyang ^a   Singh, Brij B ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSACTIVATOR PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; CALCIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; BIPOLAR DISORDER; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CEREBELLAR ATAXIA; CYTOSOL; DENDRITE; ENDOPLASMIC RETICULUM; GENE CONTROL; GENE EXPRESSION; GROWTH CONE; HUMAN; HUNTINGTON CHOREA; LONG TERM POTENTIATION; MITOCHONDRION; NERVE CELL PLASTICITY; NERVE FIBER REGENERATION; NEUROSECRETION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; RAT; REVIEW; SENSATION; ANIMAL; BRAIN; CALCIUM SIGNALING; COGNITIVE DEFECT; DEGENERATIVE DISEASE; GENETICS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CALCIUM; CALCIUM SIGNALING; CYTOSOL; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; ENDOPLASMIC RETICULUM; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; TRPC CATION CHANNELS;

EID: 77949902774     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710790966650     Document Type: Review

References (147)

1. Marty, A. The physiological role of calcium-dependent channels. Trends Neurosci., 1989, 12, 420-424.
2. Malenka, R.C.; Kauer, J.A.; Perkel, D.J.; Nicoll, R.A. The impact of postsynaptic calcium on synaptic transmission--its role in long-term potentiation. Trends Neurosci., 1989, 12, 444-450.
3. Llinas, R.R. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science, 1988, 242, 1654-1664.
4. McCormack, J.G.; Halestrap, A.P.; Denton, R.M. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev., 1990, 70, 391-425.
5. Orrenius, S.; Zhivotovsky, B.; Nicotera, P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol., 2003, 4, 552-565.
6. Bading, H.; Ginty, D.D.; Greenberg, M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science, 1993, 260, 181-186.
7. Bezprozvanny, I. Calcium signaling and neurodegenerative diseases. Trends Mol. Med., 2009, 15, 89-100.
8. Marambaud, P.; Dreses-Werringloer, U.; Vingtdeux, V. Calcium signaling in neurodegeneration. Mol. Neurodegener., 2009, 4, 20-34.
9. Aarts, M.M.; Tymianski, M. TRPM7 and ischemic CNS injury. Neuroscientist, 2005, 11, 116-123.
10. Berridge, M.J.; Bootman, M.D.; Lipp, P. Calcium - a life and death signal. Nature, 1998, 395, 645-648.
11. Dubinsky, J.M. Intracellular calcium levels during the period of delayed excitotoxicity. J. Neurosci., 1993, 13, 623-631.
12. Herman, B.; Gores, G.J.; Nieminen, A.L.; Kawanishi, T.; Harman, A.; Lemasters, J.J. Calcium and pH in anoxic and toxic injury. Crit. Rev. Toxicol., 1990, 21, 127-148.
13. Choi, D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci., 1988, 11, 465-469.
14. Arundine, M.; Tymianski, M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium, 2003, 34, 325-337.
15. Putney, J.W., Jr. A model for receptor-regulated calcium entry. Cell Calcium, 1986, 7, 1-12.
16. Parekh, A.B.; Putney, J.W., Jr. Store-operated calcium channels. Physiol. Rev., 2005, 85, 757-810.
17. Parekh, A.B.; Penner, R. Store depletion and calcium influx. Physiol. Rev., 1997, 77, 901-930.
18. Sattler, R.; Charlton, M.P.; Hafner, M.; Tymianski, M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem., 1998, 71, 2349-2364.
19. Paschen, W.; Doutheil, J.; Gissel, C.; Treiman, M. Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis. J. Neurochem., 1996, 67, 1735-1743.
20. 2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells. Neurochem. Int., 2006, 48, 696-702.
21. Putney, J.W. Physiological mechanisms of TRPC activation. Pflugers. Arch., 2005, 451, 29-34.
22. Putney, J.W., Jr. Capacitative calcium entry in the nervous system. Cell Calcium, 2003, 34, 339-344.
23. 2+ entry. Biochim. Biophys. Acta., 2009, 1793, 223-230.
24. 2+ entry. Nat. Cell Biol., 2009, 11, 669-677.
25. Feske, S.; Gwack, Y.; Prakriya, M.; Srikanth, S.; Puppel, S.H.; Tanasa, B.; Hogan, P.G.; Lewis, R.S.; Daly, M.; Rao, A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature, 2006, 441, 179-185.
26. 2+ entry. Science, 2006, 312, 1220-1223.
27. Prakriya, M.; Feske, S.; Gwack, Y.; Srikanth, S.; Rao, A.; Hogan, P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature, 2006, 443, 230-233.
28. 2+ channel activity. Proc. Natl. Acad. Sci. USA, 2006, 103, 9357-9362.
29. Ong, H.L.; Cheng, K.T.; Liu, X.; Bandyopadhyay, B.C.; Paria, B.C.; Soboloff, J.; Pani, B.; Gwack, Y.; Srikanth, S.; Singh, B.B.; Gill, D.L.; Ambudkar, I.S. Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components. J. Biol. Chem., 2007, 282, 9105-9116.
30. Liao, Y.; Erxleben, C.; Abramowitz, J.; Flockerzi, V.; Zhu, M.X.; Armstrong, D.L.; Birnbaumer, L. Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels. Proc. Natl. Acad. Sci. USA, 2008, 105, 2895-2900.
31. 2+ entry. Proc. Natl. Acad. Sci. USA, 2009, 106, 3202-3206.
32. 2+ influx. Curr. Biol., 2005, 15, 1235-1241.
33. 2+ channel function. J. Cell. Biol., 2005, 169, 435-445.
34. Zeng, W.; Yuan, J.P.; Kim, M.S.; Choi, Y.J.; Huang, G.N.; Worley, P.F.; Muallem, S. STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol. Cell, 2008, 32, 439-448.
35. 2+ concentrations. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 395-426.
36. Clapham, D.E. Calcium signaling. Cell, 2007, 131, 1047-1058.
37. Beech, D.J.; Bahnasi, Y.M.; Dedman, A.M.; Al-Shawaf, E. TRPC channel lipid specificity and mechanisms of lipid regulation. Cell Calcium, 2009, 45, 583-588.
38. Tai, Y.; Feng, S.; Du, W.; Wang, Y. Functional roles of TRPC channels in the developing brain. Pflugers. Arch., 2009, 458, 283-289.
39. Orrenius, S.; Nicotera, P. The calcium ion and cell death. J. Neural Transm. Suppl., 1994, 43, 1-11.
40. Paschen, W. Role of calcium in neuronal cell injury: which subcellular compartment is involved? Brain Res. Bull., 2000, 53, 409-413.
41. Beech, D.J. TRPC1: store-operated channel and more. Pflugers. Arch., 2005, 451, 53-60.
42. Strubing, C.; Krapivinsky, G.; Krapivinsky, L.; Clapham, D.E. Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J. Biol. Chem., 2003, 278, 39014-39019.
43. 2+ entry and embryonic rat neural stem cell proliferation. J. Neurosci., 2005, 25, 2687-2701.
44. Wu, X.; Zagranichnaya, T.K.; Gurda, G.T.; Eves, E.M.; Villereal, M.L. A TRPC1/TRPC3-mediated increase in store-operated calcium entry is required for differentiation of H19-7 hippocampal neuronal cells. J. Biol. Chem., 2004, 279, 43392-43402.
45. Li, H.S.; Xu, X.Z.; Montell, C. Activation of a TRPC3-dependent cation current through the neurotrophin BDNF. Neuron, 1999, 24, 261-273.
46. Tong, Q.; Hirschler-Laszkiewicz, I.; Zhang, W.; Conrad, K.; Neagley, D.W.; Barber, D.L.; Cheung, J.Y.; Miller, B.A. TRPC3 is the erythropoietin- regulated calcium channel in human erythroid cells. J. Biol. Chem., 2008, 283, 10385-10395.
47. Mattson, M.P.; Guthrie, P.B.; Kater, S.B. Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons. Prog. Clin. Biol. Res., 1989, 317, 333-351.
48. Arundine, M.; Tymianski, M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol. Life Sci., 2004, 61, 657-668.
49. Narayanan, K.L.; Irmady, K.; Subramaniam, S.; Unsicker, K.; von Bohlen und Halbach, O. Evidence that TRPC1 is involved in hippocampal glutamate-induced cell death. Neurosci. Lett., 2008, 446, 117-122.
50. Bollimuntha, S.; Singh, B.B.; Shavali, S.; Sharma, S.K.; Ebadi, M. TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J. Biol. Chem., 2005, 280, 2132-2140.
51. Bollimuntha, S.; Ebadi, M.; Singh, B.B. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis. Brain Res., 2006, 1099, 141-149.
52. Yao, H.; Peng, F.; Dhillon, N.; Callen, S.; Bokhari, S.; Stehno-Bittel, L.; Ahmad, S.O.; Wang, J.Q.; Buch, S. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J. Neurosci., 2009, 29, 1657-1669.
53. Chen, Q.; Surmeier, D.J.; Reiner, A. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization. Exp. Neurol., 1999, 159, 283-296.
54. Behl, C. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res., 1997, 290, 471-480.
55. Dexter, D.T.; Holley, A.E.; Flitter, W.D.; Slater, T.F.; Wells, F.R.; Daniel, S.E.; Lees, A.J.; Jenner, P.; Marsden, C.D. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord., 1994, 9, 92-97.
56. Kuloglu, M.; Ustundag, B.; Atmaca, M.; Canatan, H.; Tezcan, A.E.; Cinkilinc, N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem. Funct., 2002, 20, 171-175.
57. Hou, S.T.; MacManus, J.P. Molecular mechanisms of cerebral ischemia-induced neuronal death. Int. Rev. Cytol., 2002, 221, 93-148.
58. Sies, H. Oxidative stress: oxidants and antioxidants. Exp. Physiol., 1997, 82, 291-295.
59. Nakamura, T., Lipton, S.A. Cell death: protein misfolding and neurodegenerative diseases. Apoptosis, 2009, 14, 455-468.
60. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free. Radic. Biol. Med., 2000, 29, 323-333.
61. Gopalakrishna, R.; Jaken, S. Protein kinase C signaling and oxidative stress. Free. Radic. Biol. Med., 2000, 28, 1349-1361.
62. Berlett, B.S.; Stadtman, E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem., 1997, 272, 20313-20316.
63. Bast, A.; Haenen, G.R.; Doelman, C. Oxidants and antioxidants: state of the art. J. Am. J. Med., 1991, 91, 2S-13S.
64. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C.S.; Petersen, R.B.; Smith, M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol., 2001, 60, 759-767.
65. Cutler, R.G.; Kelly, J.; Storie, K.; Pedersen, W.A.; Tammara, A.; Hatanpaa, K.; Troncoso, J.C.; Mattson, M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 2004, 101, 2070-2075.
66. Moreira, P.I.; Smith, M.A.; Zhu, X.; Nunomura, A.; Castellani, R.J.; Perry, G. Oxidative stress and neurodegeneration. Ann. N. Y. Acad. Sci., 2005, 1043, 545-552.
67. Perry, G.; Nunomura, A.; Hirai, K.; Takeda, A.; Aliev, G.; Smith, M.A. Oxidative damage in Alzheimer's disease: the metabolic dimension. Int. J. Dev. Neurosci., 2000, 18, 417-421.
68. Orrenius, S.; Zhivotovsky, B.; Nicotera, P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell. Biol., 2003, 4, 552-565.
69. 2+ in toxic cell killing. Trends Pharmacol. Sci., 1989, 10, 281-285.
70. Ermak, G.; Davies, K.J. Calcium and oxidative stress: from cell signaling to cell death. Mol. Immunol., 2002, 38, 713-721.
71. Herson, P.S.; Lee, K.; Pinnock, R.D.; Hughes, J.; Ashford, M.L. Hydrogen peroxide induces intracellular calcium overload by activation of a non-selective cation channel in an insulin-secreting cell line. J. Biol. Chem., 1999, 274, 833-841.
72. Nicotera, P.; Bellomo, G.; Orrenius, S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol., 1992, 32, 449-470.
73. Aarts, M.M.; Tymianski, M. TRPMs and neuronal cell death. Pflugers Arch., 2005, 451, 243-249.
74. Miller, B.A. The role of TRP channels in oxidative stress-induced cell death. J. Membr. Biol., 2006, 209, 31-41.
75. Balzer, M.; Lintschinger, B.; Groschner, K. Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells. Cardiovasc. Res., 1999, 42, 543-549.
76. Poteser, M.; Graziani, A.; Rosker, C.; Eder, P.; Derler, I.; Kahr, H.; Zhu, M.X.; Romanin, C.; Groschner, K. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel: evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J. Biol. Chem., 2006, 281, 13588-13595.
77. 2+ exchanger. J. Biol. Chem., 2004, 279, 13696-13704.
78. Groschner, K.; Rosker, C.; Lukas, M. Role of TRP channels in oxidative stress. Novartis Found. Symp., 2004, 258, 222-230.
79. Giannoni, E.; Buricchi, F.; Raugei, G.; Ramponi, G.; Chiarugi, P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol., 2005, 25, 6391-6403.
80. Nakashima, I.; Kato, M.; Akhand, A.A.; Suzuki, H.; Takeda, K.; Hossain, K.; Kawamoto, Y. Redox-linked signal transduction pathways for protein tyrosine kinase activation. Antioxid. Redox. Signal., 2002, 4, 517-531.
81. Rhee, S.G.; Yang, K.S.; Kang, S.W.; Woo, H.A.; Chang, T.S. Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox. Signal., 2005, 7, 619-626.
82. Vazquez, G.; Wedel, B.J.; Kawasaki, B.T.; Bird, G.S.; Putney, J.W., Jr. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J. Biol. Chem., 2004, 279, 40521-40528
83. Ambudkar, I.S.; Brazer, S.C.; Liu, X.; Lockwich, T.; Singh, B. Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found. Symp., 2004, 258, 63-70.
84. Pani, B.; Singh, B.B. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium, 2009, 45, 625-633.
85. Parat, M.O.; Fox, P.L. Oxidative stress, caveolae and caveolin-1. Subcell Biochem., 2004, 37, 425-441.
86. Sanguinetti, A.R.; Mastick, C.C. c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. Cell Signal., 2003, 15, 289-298.
87. Crouzin, N.; de Jesus Ferreira, M.C.; Cohen-Solal, C.; Aimar, R.F.; Vignes, M.; Guiramand, J. Alpha-tocopherol-mediated long-lasting protection against oxidative damage involves an attenuation of calcium entry through TRP-like channels in cultured hippocampal neurons. Free Radic. Biol. Med., 2007, 42, 1326-1337.
88. 2+ signaling in the regulation of endothelial permeability. Vascul. Pharmacol., 2002, 39, 173-185.
89. Gokce, O.; Runne, H.; Kuhn, A.; Luthi-Carter, R. Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation. PLoS One, 2009, 4, e5292.
90. 2+. Handb. Exp. Pharmacol., 2007, 179, 527-540.
91. Chen, J.; Crossland, R.F.; Noorani, M.M.; Marrelli, S.P. Am. J. Physiol. Heart Circ. Physiol., 2009, 297, H417.
92. Yamamoto, S.; Wajima, T.; Hara, Y.; Nishida, M.; Mori, Y. Transient receptor potential channels in Alzheimer's disease. Biochim. Biophys. Acta., 2007, 1772, 958-967.
93. Chakrabarti, L.; Hurtrel, M.; Maire, M.A.; Vazeux, R.; Dormont, D.; Montagnier, L.; Hurtrel, B. Early viral replication in the brain of SIV-infected rhesus monkeys. Am. J. Pathol. 1991, 139, 1273-1280.
94. Davis, L.E.; Hjelle, B.L.; Miller, V.E.; Palmer, D.L.; Llewellyn, A.L.; Merlin, T.L.; Young, S.A.; Mills, R.G.; Wachsman, W.; Wiley, C.A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology, 1992, 42, 1736-1739.
95. Navia, B.A.; Jordan, B.D.; Price, R.W. The AIDS dementia complex: I. Clinical features. Ann. Neurol., 1986, 19, 517-524.
96. Price, R.W.; Brew, B.; Sidtis, J.; Rosenblum, M.; Scheck, A.C.; Cleary, P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 1988, 239, 586-592.
97. Javitch, J.A.; D'Amato, R.J.; Strittmatter, S.M.; Snyder, S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA, 1985, 82, 2173-2177.
98. Lotharius, J.; Dugan, L.L.; O'Malley, K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci., 1999, 19, 1284-1293.
99. Hoffman, A.F.; Gerhardt, G.A. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J. Pharmacol. Exp. Ther., 1999, 289, 455-463.
100. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci., 2001, 21, 7841-7847.
101. Patel, J.C.; Witkovsky, P.; Avshalumov, M.V.; Rice, M.E. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J. Neurosci., 2009, 29, 6568-6579.
102. Tozzi, A.; Bengtson, C.P.; Longone, P.; Carignani, C.; Fusco, F.R.; Bernardi, G.; Mercuri, N.B. Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J. Neurosci., 2003, 18, 2133-2145.
103. Kim, S.J.; Kim, Y.S.; Yuan, J.P.; Petralia, R.S.; Worley, P.F.; Linden, D.J. Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature, 2003, 426, 285-291.
104. Martorana, A.; Giampa, C.; DeMarch, Z.; Viscomi, M.T.; Patassini, S.; Sancesario, G.; Bernardi, G.; Fusco, F.R. Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. Eur. J. Neurosci., 2006, 24, 732-738.
105. Khachaturian, Z.S. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol. Aging, 1987, 8, 345-346.
106. Small, D.H. Dysregulation of calcium homeostasis in Alzheimer's disease. Neurochem. Res., 2009, 34, 1824-1829.
107. Michaelis, M.L.; Foster, C.T.; Jayawickreme, C. Regulation of calcium levels in brain tissue from adult and aged rats. Mech. Ageing Dev., 1992, 62, 291-306.
108. Arispe, N.; Rojas, E.; Pollard, H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA, 1993, 90, 567-571.
109. Katzman, R. Editorial: The prevalence and malignancy of Alzheimer disease: a major killer. Arch. Neurol., 1976, 33, 217-218.
110. De Strooper, B.; Beullens, M.; Contreras, B.; Levesque, L.; Craessaerts, K.; Cordell, B.; Moechars, D.; Bollen, M.; Fraser, P.; George-Hyslop, P.S.; Van Leuven, F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem., 1997, 272, 3590-3598.
111. Cook, D.G.; Sung, J.C.; Golde, T.E.; Felsenstein, K.M.; Wojczyk, B.S.; Tanzi, R.E.; Trojanowski, J.Q.; Lee, V.M.; Doms, R.W. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA, 1996, 93, 9223-9228.
112. Scheuner, D.; Eckman, C.; Jensen, M.; Song, X.; Citron, M.; Suzuki, N.; Bird, T.D.; Hardy, J.; Hutton, M.; Kukull, W.; Larson, E.; Levy-Lahad, E.; Viitanen, M.; Peskind, E.; Poorkaj, P.; Schellenberg, G.; Tanzi, R.; Wasco, W.; Lannfelt, L.; Selkoe, D.; Younkin, S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med., 1996, 2, 864-870.
113. Haass, C. Presenilins: genes for life and death. Neuron, 1997, 18, 687-690.
114. Green, K.N.; LaFerla, F.M. Linking calcium to Abeta and Alzheimer's disease. Neuron, 2008, 59, 190-194.
115. Guo, Q.; Sopher, B.L.; Furukawa, K.; Pham, D.G.; Robinson, N.; Martin, G.M.; Mattson, M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci., 1997, 17, 4212-4222.
116. Yoo, A.S.; Cheng, I.; Chung, S.; Grenfell, T.Z.; Lee, H.; Pack-Chung, E.; Handler, M.; Shen, J.; Xia, W.; Tesco, G.; Saunders, A.J.; Ding, K.; Frosch, M.P.; Tanzi, R.E.; Kim, T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron, 2000, 27, 561-572.
117. Tu, H.; Nelson, O.; Bezprozvanny, A.; Wang, Z.; Lee, S.F.; Hao, Y.H.; Serneels, L.; De Strooper, B.; Yu, G.; Bezprozvanny, I. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell, 2006, 126, 981-993.
118. Bezprozvanny, I.; Mattson, M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci., 2008, 31, 454-463.
119. 2+ entry in familial Alzheimer's disease. Biochim. Biophys. Acta., 2009, 1793, 1050-1057.
120. 2+ entry into HEK293 cells. Cell Signal., 2005, 17, 437-445.
121. 2+-releasing messengers: are they important in the nervous system? Trends Neurosci., 1999, 22, 488-495.
122. Waterman, S.A. Voltage-gated calcium channels in autonomic neuroeffector transmission. Prog. Neurobiol., 2000, 60, 181-210.
123. Thoenen, H. Neurotrophins and neuronal plasticity. Science, 1995, 270, 593-598.
124. Li, Y.X.; Zhang, Y.; Lester, H.A.; Schuman, E.M.; Davidson, N. Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J. Neurosci., 1998, 18, 10231-10240.
125. Tyler, W.J.; Perrett, S.P.; Pozzo-Miller, L.D. The role of neurotrophins in neurotransmitter release. Neuroscientist, 2002, 8, 524-531.
126. 2+ influx. Mol. Cell., 2004, 15, 635-646.
127. Chameau, P.; Van de Vrede, Y.; Fossier, P.; Baux, G. Ryanodine-, IP3- and NAADP-dependent calcium stores control acetylcholine release. Pflugers Arch., 2001, 443, 289-296.
128. Cheramy, A.; Barbeito, L.; Godeheu, G.; Glowinski, J. Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci. Lett., 1992, 147, 209-212.
129. Glickstein, M. Mossy-fibre sensory input to the cerebellum. Prog. Brain Res., 1997, 114, 251-259.
130. Matilla-Duenas, A. The highly heterogeneous spinocerebellar ataxias: from genes to targets for therapeutic intervention. Cerebellum, 2008, 7, 97-100.
131. Lim, J.; Hao, T.; Shaw, C.; Patel, A.J.; Szabo, G.; Rual, J.F.; Fisk, C.J.; Li, N.; Smolyar, A.; Hill, D.E.; Barabasi, A.L.; Vidal, M.; Zoghbi, H.Y. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell, 2006, 125, 801-814.
132. Becker, E.B.; Oliver, P.L.; Glitsch, M.D.; Banks, G.T.; Achilli, F.; Hardy, A.; Nolan, P.M.; Fisher, E.M.; Davies, K.E. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc. Natl. Acad. Sci. USA, 2009, 106, 6706-6711.
133. Wu, D.; Huang, W.; Richardson, P.M.; Priestley, J.V.; Liu, M. TRPC4 in rat dorsal root ganglion neurons is increased after nerve injury and is necessary for neurite outgrowth. J. Biol. Chem., 2008, 283, 416-426.
134. Wang, G.X.; Poo, M.M. Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones. Nature, 2005, 434, 898-904.
135. Bezzerides, V.J.; Ramsey, I.S.; Kotecha, S.; Greka, A.; Clapham, D.E. Rapid vesicular translocation and insertion of TRP channels. Nat. Cell. Biol., 2004, 6, 709-720.
136. Greka, A.; Navarro, B.; Oancea, E.; Duggan, A.; Clapham, D.E. TRPC5 is a regulator of hippocampal neurite length and growth cone morphology. Nat. Neurosci., 2003, 6, 837-845.
137. Riccio, A.; Li, Y.; Moon, J.; Kim, K.S.; Smith, K.S.; Rudolph, U.; Gapon, S.; Yao, G.L.; Tsvetkov, E.; Rodig, S.J.; Van't Veer, A.; Meloni, E.G.; Carlezon, W.A., Jr.; Bolshakov, V.Y.; Clapham, D.E. Essential role for TRPC5 in amygdala function and fear-related behavior. Cell, 2009, 137, 761-772.
138. Redmond, L.; Ghosh, A. Regulation of dendritic development by calcium signaling. Cell Calcium, 2005, 37, 411-416.
139. Wu, G.Y.; Cline, H.T. Stabilization of dendritic arbor structure in vivo by CaMKII. Science, 1998, 279, 222-226.
140. Becker, L.E.; Armstrong, D.L.; Chan, F. Dendritic atrophy in children with Down's syndrome. Ann. Neurol., 1986, 20, 520-526.
141. Dierssen, M.; Ramakers, G.J. Dendritic pathology in mental retardation: from molecular genetics to neurobiology. Genes Brain. Behav., 2006, 5(Suppl 2), 48-60.
142. Aizawa, H.; Hu, S.C.; Bobb, K.; Balakrishnan, K.; Ince, G.; Gurevich, I.; Cowan, M.; Ghosh, A. Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science, 2004, 303, 197-202.
143. Gaudilliere, B.; Konishi, Y.; de la Iglesia, N.; Yao, G.; Bonni, A. A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. Neuron, 2004, 41, 229-241.
144. Tai, Y.; Feng, S.; Ge, R.; Du, W.; Zhang, X.; He, Z.; Wang, Y. TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway. J. Cell Sci., 2008, 121, 2301-2307.
145. Owsianik, G.; Talavera, K.; Voets, T.; Nilius, B. Permeation and selectivity of TRP channels. Annu. Rev. Physiol., 2006, 68, 685-717.
146. Munsch, T.; Freichel, M.; Flockerzi, V.; Pape, H.C. Contribution of transient receptor potential channels to the control of GABA release from dendrites. Proc. Natl. Acad. Sci. USA, 2003, 100, 16065-16070
147. Riccio, A.; Medhurst, A.D.; Mattei, C.; Kelsell, R.E.; Calver, A.R.; Randall, A.D.; Benham, C.D.; Pangalos, M.N. mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res. Mol. Brain Res., 2002, 109, 95-104.